Winston Medical Supply Co., Ltd. (6817.TWO)

TWD 91.2

(0.0%)

Market Cap (In TWD)

1.67 Billion

Revenue (In TWD)

709.07 Million

Net Income (In TWD)

158.75 Million

Avg. Volume

38.36 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
87.0-145.5
PE
-
EPS
-
Beta Value
0.1
ISIN
TW0006817000
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
-
Employee Count
-
Website
https://www.winston.com.tw
Ipo Date
2021-02-24
Details
Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products. It offers sterile ophthalmic preparations comprising gels, suspensions, solutions, and emulsions; hormone preparations, which primarily cover birth control and oral suspension for cancer related cachexia; external use preparations comprising ointments; and other oral preparations, which are in oral dosage forms, such as powders, troches, tables, film coated tablets, chewables, and capsules for the treatment of colds, gastrointestinal issues, or other indications. The company was founded in 1974 and is based in Tainan City, Taiwan. Winston Medical Supply Co., Ltd. is a subsidiary of Medigen Biotechnology Corp.